Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy
Background: Decreased antiretroviral therapy persistence is associated with increased rates of virologic failure, development of antiretroviral resistance, and increased morbidity and mortality. Different therapeutic strategies, such as single-tablet regimens (STR) and less-drug regimens (LDR), have...
| Published in: | Farmacia Hospitalaria |
|---|---|
| Main Authors: | Rocio Jiménez-Galán, Maria-Rosa Cantudo Cuenca, María Aguas Robustillo-Cortés, Y Borrego Izquierdo, Carmen Victoria Almeida- Gonzalez, Ramón Morillo-Verdugo |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-07-01
|
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/10453.pdf |
Similar Items
Influence of antiretroviral therapy on frailty among people living with HIV
by: Enrique Contreras Macías, et al.
Published: (2025-04-01)
by: Enrique Contreras Macías, et al.
Published: (2025-04-01)
Concordance between pharmacotherapeutic complexity calculated and perceived by HIV+ patients with antiretroviral treatment
by: Mercedes Manzano-García, et al.
Published: (2019-01-01)
by: Mercedes Manzano-García, et al.
Published: (2019-01-01)
Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
by: Chua Arlene C, et al.
Published: (2012-06-01)
by: Chua Arlene C, et al.
Published: (2012-06-01)
SELECTION OF AN ANTIRETROVIRAL REGIMEN BASED ON THE RESISTANCE DATA
by: O. G. YURIN, et al.
Published: (2017-05-01)
by: O. G. YURIN, et al.
Published: (2017-05-01)
Circulating levels of inflammatory mediators in pregnant people living with HIV according to antiretroviral therapy regimen
by: Stephanie Hindle, et al.
Published: (2024-01-01)
by: Stephanie Hindle, et al.
Published: (2024-01-01)
Virological outcomes of dolutegravir-based versus other antiretroviral regimens in people living with HIV: A systematic review and meta-analysis
by: Letebrhan Weldemhret, et al.
Published: (2026-03-01)
by: Letebrhan Weldemhret, et al.
Published: (2026-03-01)
Antiretroviral regimen change among people infected with HIV: evidence from a cross-sectional study in China
by: Junfang Xu, et al.
Published: (2018-09-01)
by: Junfang Xu, et al.
Published: (2018-09-01)
Antiretroviral therapy persistence among treatment-experienced people with HIV and mental health disorders and/or substance use disorders in the USA (2017–2024): a retrospective cohort study
by: Uche Mordi, et al.
Published: (2026-04-01)
by: Uche Mordi, et al.
Published: (2026-04-01)
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
by: Eva Agnes Odongpiny Laker, et al.
Published: (2019-03-01)
by: Eva Agnes Odongpiny Laker, et al.
Published: (2019-03-01)
Factors associated with incomplete adherence to integrase strand transfer inhibitor-containing single-tablet regimen among Japanese people living with HIV
by: Yusuke Kunimoto, et al.
Published: (2024-06-01)
by: Yusuke Kunimoto, et al.
Published: (2024-06-01)
The cost-effectiveness analysis of single-tablet efavirenz-based regimen among HIV-1 infected adults in China
by: Haijun Zhang, et al.
Published: (2025-05-01)
by: Haijun Zhang, et al.
Published: (2025-05-01)
Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment
by: Hines DM, et al.
Published: (2019-11-01)
by: Hines DM, et al.
Published: (2019-11-01)
Fitness Cost of Antiretroviral Drug Resistance Mutations on the <i>pol</i> Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure
by: James R. Hunter, et al.
Published: (2021-11-01)
by: James R. Hunter, et al.
Published: (2021-11-01)
Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients
by: Ruxandra-Cristina Marin, et al.
Published: (2021-08-01)
by: Ruxandra-Cristina Marin, et al.
Published: (2021-08-01)
Modification of antiretroviral therapy regimen: Incidence and predictors in two major HIV/AIDS treatment centers in the Southwest Region of Cameroon
by: Elvis Tajoache Amin, et al.
Published: (2018-01-01)
by: Elvis Tajoache Amin, et al.
Published: (2018-01-01)
Switching to a Bictegravir Single Tablet Regimen in Elderly People Living with HIV-1: Data Analysis from the BICTEL Cohort
by: Alessandro Lazzaro, et al.
Published: (2021-12-01)
by: Alessandro Lazzaro, et al.
Published: (2021-12-01)
Durability of single tablet regimen for patients with HIV infection in Southern Taiwan: data from a real-world setting
by: Hui-Min Chang, et al.
Published: (2022-01-01)
by: Hui-Min Chang, et al.
Published: (2022-01-01)
Two’s a Company, Three’s a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living with HIV-1
by: Melissa Badowski, et al.
Published: (2020-03-01)
by: Melissa Badowski, et al.
Published: (2020-03-01)
Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype
by: Pierluigi Francesco Salvo, et al.
Published: (2023-03-01)
by: Pierluigi Francesco Salvo, et al.
Published: (2023-03-01)
Interaction between antiretroviral therapy regimens and body mass index on triglyceride levels in people living with HIV: a cross-sectional and longitudinal study
by: Yide Xu, et al.
Published: (2024-07-01)
by: Yide Xu, et al.
Published: (2024-07-01)
Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure
by: Alberton F, et al.
Published: (2024-04-01)
by: Alberton F, et al.
Published: (2024-04-01)
Effectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Cohort Study (VACS)
by: Lei Yan, et al.
Published: (2024-12-01)
by: Lei Yan, et al.
Published: (2024-12-01)
The association between adherence to antiretroviral therapy and viral suppression under dolutegravir‐based regimens: an observational cohort study from Uganda
by: Zachary Wagner, et al.
Published: (2024-08-01)
by: Zachary Wagner, et al.
Published: (2024-08-01)
Drug induced liver injury in HIV patients on dolutegravir based antiretroviral therapy regimens in Wolaita Sodo comprehensive specialized hospital
by: Firew Abraham, et al.
Published: (2025-07-01)
by: Firew Abraham, et al.
Published: (2025-07-01)
HIV drug resistance in children and adolescents on NNRTI-based antiretroviral therapy and subsequent virologic response to dolutegravir-based regimens in Ghana
by: Adwoa K.A Afrane, et al.
Published: (2025-07-01)
by: Adwoa K.A Afrane, et al.
Published: (2025-07-01)
Bone loss in young adults with HIV following antiretroviral therapy containing tenofovir disoproxil fumarate regimen using machine learning
by: Ling Chen, et al.
Published: (2025-04-01)
by: Ling Chen, et al.
Published: (2025-04-01)
A better regulation is required in viral hepatitis smartphone applications
by: M.ª R. Cantudo-Cuenca, et al.
Published: (2014-03-01)
by: M.ª R. Cantudo-Cuenca, et al.
Published: (2014-03-01)
Perinatal exposure to atazanavir-based antiretroviral regimens in a mouse model leads to differential long-term motor and cognitive deficits dependent on the NRTI backbone
by: Shreya H. Dhume, et al.
Published: (2024-04-01)
by: Shreya H. Dhume, et al.
Published: (2024-04-01)
Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025
by: Kiho Tanaka, et al.
Published: (2025-10-01)
by: Kiho Tanaka, et al.
Published: (2025-10-01)
Response to Commentary: Long-term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens
by: Sergio Serrano-Villar, et al.
Published: (2022-06-01)
by: Sergio Serrano-Villar, et al.
Published: (2022-06-01)
Consensus document on enhancing medication adherence in patients with the human immunodeficiency virus receiving antiretroviral therapy
by: Ramón Morillo-Verdugo, et al.
Published: (2020-07-01)
by: Ramón Morillo-Verdugo, et al.
Published: (2020-07-01)
Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV
by: Zhenyan Wang, et al.
Published: (2024-11-01)
by: Zhenyan Wang, et al.
Published: (2024-11-01)
Design and validation of a satisfaction survey with pharmaceutical care received in hospital pharmacyconsultation
by: Patricia Monje-Agudo, et al.
Published: (2015-02-01)
by: Patricia Monje-Agudo, et al.
Published: (2015-02-01)
The challenges experienced by nongovernmental organisations with regard to the roll-out of antiretroviral therapy in KwaZulu-Natal
by: J. Michel, et al.
Published: (2013-06-01)
by: J. Michel, et al.
Published: (2013-06-01)
Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral–BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens
by: Lu Chen, et al.
Published: (2026-04-01)
by: Lu Chen, et al.
Published: (2026-04-01)
Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study
by: Sergio Serrano-Villar, et al.
Published: (2022-11-01)
by: Sergio Serrano-Villar, et al.
Published: (2022-11-01)
Dolutegravir-based regimens in treatment-naive and treatment-experienced aging populations: analyses of 6 phase III clinical trials
by: Frank Spinelli, et al.
Published: (2021-07-01)
by: Frank Spinelli, et al.
Published: (2021-07-01)
Modern antiretroviral regimens
by: A. V. Kravchenko
Published: (2016-12-01)
by: A. V. Kravchenko
Published: (2016-12-01)
Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults
by: Simbarashe Takuva, et al.
Published: (2013-05-01)
by: Simbarashe Takuva, et al.
Published: (2013-05-01)
Corrigendum: Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study
by: Sergio Serrano-Villar, et al.
Published: (2023-02-01)
by: Sergio Serrano-Villar, et al.
Published: (2023-02-01)
Similar Items
-
Influence of antiretroviral therapy on frailty among people living with HIV
by: Enrique Contreras Macías, et al.
Published: (2025-04-01) -
Concordance between pharmacotherapeutic complexity calculated and perceived by HIV+ patients with antiretroviral treatment
by: Mercedes Manzano-García, et al.
Published: (2019-01-01) -
Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
by: Chua Arlene C, et al.
Published: (2012-06-01) -
SELECTION OF AN ANTIRETROVIRAL REGIMEN BASED ON THE RESISTANCE DATA
by: O. G. YURIN, et al.
Published: (2017-05-01) -
Circulating levels of inflammatory mediators in pregnant people living with HIV according to antiretroviral therapy regimen
by: Stephanie Hindle, et al.
Published: (2024-01-01)
